News / Taiwan / cnyes
Adimmune August Revenue Grows 34% YoY
Health Technology · Biotechnology · cnyes · 2026-09-04
4142
Adimmune (4142) reported August revenue of NT$97.92 million, a 34.46% year-over-year increase, showing resilience compared to the biotech sector index.
What Happened
Revenue Overview: Adimmune (4142) reported August 2026 revenue of NT$97.92 million, reflecting a 34.46% year-over-year increase, though it experienced a 68.23% month-over-month decline.
Cumulative Results: The company's cumulative revenue for the first eight months of 2026 reached NT$555 million, representing a year-to-date growth of 12.56%.
Stock Performance: Trading at NT$17.55, the stock declined 1.68% over the past five days, which is significantly better than the 9.59% drop seen in the biotech sector index.
Business Operations: Adimmune specializes in the manufacturing and development of vaccines, serums, diagnostic reagents, and biological products, alongside import and export services.
Read original
More in Health Technology
Health Technology · cnyes · 2026-09-04
Taiwan-based Huaan (6657) is set to raise NT$300 million through a new share issuance to fund clinical trials for its F705PD and F703EB drug candidates.
6657
Health Technology · economic_daily · 2026-09-04
The Taiwan Index Plus Corporation has announced its quarterly index adjustments, with PharmaEssentia entering the Taiwan 50 index while Alchip is removed, effective September 21.
0050
Health Technology · economic_daily · 2026-09-04
FTSE Russell has unveiled its latest quarterly index review for Taiwan, with PharmaEssentia joining the Taiwan 50 Index while Alchip-KY is removed.
1301, 2371, 2379, 2441, 2615, 2637, 2845, 2855, 3006, 3189, 3406, 3450, 3481, 3661, 4583, 4919, 6005, 6446, 6944, 6949, 7610, 8039, 8454
Latest in Taiwan
Producer Manufacturing · cnyes · 2026-09-04
Kaori (8996) reported a strong August 2026 revenue of NT$1.204 billion, marking a 112.84% year-over-year increase and signaling robust growth momentum.
8996
Electronic Technology · cnyes · 2026-09-04
Huayouyi (6877) posted August 2026 revenue of NT$55.15 million, achieving a 140.18% year-over-year increase despite a slight monthly decline.
6877
Electronic Technology · cnyes · 2026-09-04
Jm-KY (6525) reported August 2026 revenue of NT$609 million, a 30.53% year-over-year increase, reflecting steady growth in the power semiconductor sector.
6525
Electronic Technology · cnyes · 2026-09-04
Pu-Cheng (6129) reported August 2026 revenue of NT$129 million, a 43.6% year-over-year increase, highlighting strong growth in consumer IC demand.
6129